Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/1999
09/08/1999CN1227846A Process for producing hydrophobic polypeptides, proteins or peptides
09/07/1999US5948952 Xeroderma pigmentosum-deficient mouse
09/07/1999US5948900 The present invention relates generally to the fields of bacterial capsule formation and the genes responsible for polysaccharide synthesis.
09/07/1999US5948895 Process for producing a glycosylated amino compound
09/07/1999US5948892 Analogs of macrophage stimulating protein
09/07/1999US5948891 Cytoplasmic modulators of integrin binding
09/07/1999US5948890 The polypeptide of the present invention is a human 7-transmembrane receptor. the transmembrane receptor is a g-protein coupled receptor. more particularly, the 7-transmembrane receptor has been putatively identified as a
09/07/1999US5948889 Purified bacterial cell division protein for screening libraries of compounds
09/07/1999US5948888 Neural thread protein gene expression and detection of Alzheimer's disease
09/07/1999US5948887 Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
09/07/1999US5948883 Human CRM1 Protein
09/07/1999US5948790 Retroviral protease inhibitors
09/07/1999US5948764 Methods for treatment of multiple sclerosis utilizing peptide analogues of human myelin basic protein
09/07/1999US5948763 Inhibitory peptide having a length of three to fifteen amino acids and comprising a portion of three to eight amino acids, which portion is hydrophobic and has one or more .beta.-sheet blocking amino acid residues therein
09/07/1999US5948761 For treating conditions characterized by high levels of extracellular fluid; human or veterinary medicine
09/07/1999US5948759 Factor VII fragment 82-128 and its use in blood-clotting disorders
09/07/1999US5948758 Methods for treating various disease states by reducing adhesion of leukocytes of target cells
09/07/1999US5948754 Cyclic hexapeptides, their production and use
09/07/1999US5948752 Suppressory agents against hypercoagulation
09/07/1999US5948750 Conjugates useful in the treatment of prostate cancer
09/07/1999US5948682 Preparation of heterologous proteins on oil bodies
09/07/1999US5948677 This invention relates to epitope tagging, in particular, to improved epitope tags, the nucleotide sequences that encode them, methods for using the nucleotide sequences and tags, and resulting cellular and multicellular products.
09/07/1999US5948676 Immediate early protein from Kaposi's sarcoma-associated herpesvirus, DNA encoding same and uses thereof
09/07/1999US5948668 Gene expression of proenzyme from recombinant bacterial cell, solubilizing proenzyme, incubation at alkaline ph permitting folding, cleaving to activate enzyme, purification of active enzyme; cost efficient and pure
09/07/1999US5948667 Xylanase obtained from an anaerobic fungus
09/07/1999US5948656 Proteins which bind to cytolytic lymphocyte cytoplasmic granule associated rna binding proteins; anticarcinogenic agents; treatment of graft vs. host disease, allograft rejection, transplantation organ rejections
09/07/1999US5948646 Making complementary dna from rna isolated from cancer or preneoplastic cells, ligating into constructs forming library, introducing library into host cells, culturing causing gene expression, recovering immunogenic complexes
09/07/1999US5948644 Polynucleotides encoding excretory/secretory proteins of parasitic nematodes, host cells transformed therewith
09/07/1999US5948643 Modulators of BRCA1 activity
09/07/1999US5948642 Polynucleotide from staphylococcus aureus which codes for resolvase polypeptide; for diagnosis of infections; as bactericides; for screening for novel antibiotics; treatment of toxic shock syndrome
09/07/1999US5948641 The discovery of a metal response element binding protein and the polynucleotides encoding it satisfies a need in the art by providing new compositions which are useful in the diagnosis, prevention and treatment of cancer, tissue damage and
09/07/1999US5948640 Mammalian additional sex combs (mammalian Asx) acts as a tumor suppressor
09/07/1999US5948639 TGF-β pathway genes
09/07/1999US5948638 TNF receptor death domain ligand proteins
09/07/1999US5948637 Human and rat hypoxic stress proteins and DNAs encoding therefor
09/07/1999US5948636 DNA and host cells encoding a cell surface protein of porphyromonas gingivalis
09/07/1999US5948635 Totally Synthetic Affinity Reagents
09/07/1999US5948634 Neural thread protein gene expression and detection of alzheimer's disease
09/07/1999US5948629 Zonula occludens toxic receptor
09/07/1999US5948626 Method of detecting human phospholipase inhibitor
09/07/1999US5948623 Method for testing the differentiation status in pancreatic cells of a mammal
09/07/1999US5948619 New compositions which are useful in the diagnosis, prevention and treatment of cancer and neuronal disorders.
09/07/1999US5948613 Methods of screening for risk of cancer using human lactoferrin DNA probe or primer
09/07/1999US5948611 Primers and methods for detecting mutations in the procollagen II gene (COL2A1) that indicate a genetic predisposition for a COL2A1-associated disease
09/07/1999US5948609 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
09/07/1999US5948413 Method and vaccine for treatment of pythiosis insidiosi in humans and lower animals
09/07/1999US5948412 Vaccine for Moraxella catarrhalis
09/07/1999US5948410 Animal cell culture
09/07/1999US5948409 T cell receptor ligands and methods of using same
09/07/1999US5948408 DNA encoding bactericidal/permeability-increasing proteins
09/07/1999US5947708 Axial flow valve system for linear compressor
09/07/1999CA2138765C Recombinant haemophilus influenzae protein and nucleotide sequence encoding same
09/07/1999CA2125486C Platelet gpiiia p1 a1 and p1 a2 epitopes, their preparation and use
09/07/1999CA2072982C Hepatitis a vaccines
09/07/1999CA2026041C Deacetoxycephalosporin c hydroxylase
09/07/1999CA1340729C Ryegrass pollen allergen
09/07/1999CA1340726C Redox amino acids and peptides containing them
09/05/1999CA2264431A1 Canine factor viii gene, protein and methods of use
09/02/1999WO1999043843A1 A simplified system for generating recombinant adenoviruses
09/02/1999WO1999043841A1 Self-replicating vector for dna immunization against hiv
09/02/1999WO1999043840A1 Self-regulated apoptosis of inflammatory cells by gene therapy
09/02/1999WO1999043839A1 Vaccines, immunotherapeutics and methods for using the same
09/02/1999WO1999043835A2 Methods for producing a polypeptide in a bacillus cell
09/02/1999WO1999043834A2 P-selectin ligand protein, including tetrameric fusion proteins
09/02/1999WO1999043832A2 Human proteinase molecules
09/02/1999WO1999043829A2 Cell cycle related proteins
09/02/1999WO1999043828A1 Human homolog of the drosophila protein 'fused'
09/02/1999WO1999043824A1 Cultivar specificity gene from the rice pathogen magnaporthe grisea, and methods of use
09/02/1999WO1999043822A1 Nitric oxide as an activator of the plant pathogen defense systems
09/02/1999WO1999043821A1 Genes for activation of plant pathogen defense systems
09/02/1999WO1999043820A1 PLANT TRANSLATION FACTOR eIF-4E
09/02/1999WO1999043819A1 Family of maize pr-1 genes and promoters
09/02/1999WO1999043818A1 Novel dna fragments ordering gene expression predominant in flower organ
09/02/1999WO1999043814A1 Therapeutic blockade of icer synthesis to prevent icer-mediated inhibition of immune cell activity
09/02/1999WO1999043813A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof
09/02/1999WO1999043812A2 Dlc-1 gene, a putative tumors suppressor gene
09/02/1999WO1999043811A1 cDNA ENCODING A GENE BOG (B5T OVER-EXPRESSED GENE) AND ITS PROTEIN PRODUCT
09/02/1999WO1999043810A1 Mutant heparin cofactor ii
09/02/1999WO1999043809A2 Protease-activated receptor 4 and uses thereof
09/02/1999WO1999043808A1 Human c-maf compositions and methods of use thereof
09/02/1999WO1999043807A2 Human channel-related molecules
09/02/1999WO1999043806A1 Human smn-like protein
09/02/1999WO1999043805A1 Human protein kinase c inhibitor
09/02/1999WO1999043804A1 Mouse tcf-3 and tcf-4 and tumourigenesis related to wnt/wingless signalling
09/02/1999WO1999043803A1 Genomic gene encoding hm1.24 antigen protein and promoter thereof
09/02/1999WO1999043802A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
09/02/1999WO1999043801A1 Anti-angiogenic vaccines: substances and methods relating thereto
09/02/1999WO1999043800A1 TUMOR ASSOCIATED ANTIGEN 791Tgp72
09/02/1999WO1999043798A1 Methods and compositions using tumor specific soluble interleukin-2 receptor alpha molecules
09/02/1999WO1999043797A2 Constitutive maize promoters
09/02/1999WO1999043789A1 Efficient aav vectors
09/02/1999WO1999043784A2 Novel compositions and methods for enhancing osseous growth, repair and regeneration
09/02/1999WO1999043783A2 TRANSGENIC MOUSE HAVING A LacZ REPORTER GENE UNDER THE CONTROL OF THE N-CAM PROMOTER
09/02/1999WO1999043713A1 Enhancing the circulating half-life of antibody-based fusion proteins
09/02/1999WO1999043712A1 Method for producing a factor viii/von willebrand factor complex
09/02/1999WO1999043711A1 G protein-coupled receptor antagonists
09/02/1999WO1999043710A1 Prostate-specific membrane antigens and methods of making and using
09/02/1999WO1999043709A2 Melanocortin receptor antagonists and modulations of melanocortin receptor activity
09/02/1999WO1999043708A1 Glp-1 derivatives of glp-1 and exendin with protracted profile of action
09/02/1999WO1999043707A1 N-terminally modified glp-1 derivatives